My watch list  


Companies Generics

Torrent Pharmaceuticals Limited, India

Torrent Pharma, with annual revenues of more than Rs 8,000 crores, is the flagship Company of the Torrent Group, with group revenues of Rs 20,500 crores. It is ranked 8th in the Indian Pharma Market and is among the Top 5 in the therapeutic segments of Cardiovascular (CV), Central Nervous System (CN more

Zentiva N.V., Czechia

Zentiva N.V. is an international pharmaceutical company that develops, manufactures and markets modern branded generic pharmaceutical products. It is a market leader in the Czech Republic, Turkey, Romania, Poland, Slovakia and Russia and grows dynamically in Bulgaria, the Ukraine and the Baltic coun more

Dr.Reddy's Laboratories Ltd., India

Dr. Reddy's Laboratories Ltd. is an integrated pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services & Active Ingredients, Global Generics and Proprietary Products – Dr. Reddy's offers a portfoli more

All companies on generics

News Generics

  • This one-atom chemical reaction could transform drug discovery

    Pharmaceutical synthesis is often quite complex; simplifications are needed to speed up the initial phase of drug development and lower the cost of generic production. Now, in a study recently published in Science, researchers from Osaka University have discovered a chemical reaction that could tran more

  • Price competition for generic drugs linked to increase in manufacturing-related recalls

    Researchers from three universities have found that extreme price competition in the generic pharmaceutical market -- designed to make medications more affordable -- may be putting more patients at serious health risk, as evidenced by a higher number of product recalls caused by manufacturing-relate more

  • Sanofi sells European generics business

    Advent International and Sanofi have entered into exclusive negotiations under which Advent would acquire Zentiva, Sanofi's European generics business for €1,9 billion. Advent's offer is firm, binding and fully financed. Advent is a global investor, with over 25 years' experience of investing in the more

All news on generics


This is where you can add this topic to your personal favourites

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE